• Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

    Source: Nasdaq GlobeNewswire / 27 Nov 2023 08:00:00   America/New_York

    CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.

    JMP Securities Hematology and Oncology Summit
    Fireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET
    Location: Virtual

    About Vor Bio
    Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contact:

    Media & Investors
    Sarah Spencer
    +1 857-242-6076
    sspencer@vorbio.com


    Primary Logo

Share on,